# Chlorogen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chlorogen

- Industry: Biotechnology
- Headquarters: St. Louis, US
- Website: www.chlorogen.com
- Total disclosed funding: $6M
- Latest round: Series B (Dec 28, 2005)
- Investors on record: 4

## About

Chlorogen Inc. is a biopharmaceutical company. It engages in the development and manufacture of proteins for human therapy. The company, through its chloroplast transformation technology (CTT), offers plant made drugs for the treatment and prevention of human diseases, as well as for treatment of women’s reproductive cancers.

## Funding rounds

- Series B, Dec 28, 2005, $6M — Burrill & Company, Prolog Ventures, Redmont Venture Partners, 180 Degree Capital

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series B
- Prolog Ventures (https://capitalatlas.ai/funds/prolog-ventures) — Series B
- Redmont Venture Partners (https://capitalatlas.ai/funds/redmont-venture-partners) — Series B
- 180 Degree Capital (https://capitalatlas.ai/funds/180-degree-capital) — Series B
